Remember Google's smart contact lenses? Well, now the giant Swiss pharmaceutical company Novartis is turning them into a commercial reality.
The two companies have announced that Novartis is licensing Google's technology to create special contact lenses for diabetic patients. The new lenses will analyse tear fluid in the eye and provide real-time, constant measurement of an individual's glucose levels. That data will then be transmitted wirelessly to a mobile, enabling users to easily monitor their condition
Novartis appears to have plans beyond simple glucose level monitoring, though. It plans to use them to treat people with presbyopia (those whom can no longer read without glasses) and is even considering the possibility of implanting the lens directly into the eye.